E88.810 Insurance Policy Changes

ICD-10 E88.810 is officially defined as "Metabolic syndrome." code E88.810 is referenced in 5 tracked payer policy changes from Blue Cross of Idaho, Aetna, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code E88.810 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Blue Cross of Idaho · Effective Nov 20, 2025Medium impact
2.01.92 - Fecal Microbiota Transplantation - name of bacteria was updated to Clostridioides (formerly Clostridium) difficile. Clarification on recurrent infection. Policy intent unchanged.
Blue Cross of Idaho's fecal microbiota transplantation policy MP 2.01.92 was updated to use the current name Clostridioides difficile and to clarify recurrent infection, and the policy intent is unchanged. FMT using a conventional compounded product may be considered medically necessary for recurrent C. difficile infection after at least 2 recurrences that are refractory to standard antibiotic treatment. FMT using an FDA-approved product may be considered medically necessary under the same recurrence condition only when the recipient is 18 years of age or older, and FMT is considered investigational in all other situations. The version effective 11/20/2025 is already effective as of the analysis date of 2026-11-05.
Aetna · Identified Sep 29, 2026Medium impact
Abdominoplasty, Suction Lipectomy, and Ventral Hernia Repair (CPB 0211, reviewed 2026-08-18)
Aetna considers panniculectomy or apronectomy medically necessary when the panniculus hangs below the pubis on high-quality color photographs, the medical records show chronic intertrigo that recurs over 3 months or stays refractory to 3 months of appropriate therapy, and weights have been stable for the most recent 3 months; for bariatric patients, at least 12 months must have elapsed since the bariatric plateau. Repair of a true incisional or ventral hernia is considered medically necessary, and component separation is considered a medically necessary adjunct when a ventral hernia is larger than 10 cm in any direction, involves loss of domain, is 7 to 10 cm wide with a width to rectus abdominis width ratio of 2 or more, is complex with tissue loss, or follows prior failed repairs. Liposuction, lipectomy and excision of excessive skin are considered medically necessary for lipedema of the extremities after pain and disability persist despite 3 months or more of conservative management, and suction lipectomy of the trunk is considered medically necessary for lipedema when the specified pain, functional impairment and conservative-treatment criteria are met. Abdominoplasty, lipoabdominoplasty, suction lipectomy for indications other than lipedema and lymphedema, and panniculectomy that does not meet the criteria are considered cosmetic, repair of diastasis recti is considered not medically necessary, and several ventral hernia techniques, including enhanced-view totally extra-peritoneal repair, TAPPRA and peritoneal flap hernioplasty, are considered experimental, investigational or unproven.
Aetna · Identified Aug 15, 2026Medium impact
Fecal Bacteriotherapy (CPB 0844, reviewed 2026-03-25)
Aetna's commercial clinical policy bulletin 0844 covers fecal bacteriotherapy. It considers fecal microbiota transplant medically necessary for Clostridium difficile infection (CDI) confirmed by a positive C. difficile toxin stool test that has recurred after at least one course of adequate antibiotic therapy. It considers a single rectal dose of Rebyota (fecal microbiota, live-jslm) medically necessary for preventing CDI when the policy's criteria are met, and it considers other listed indications, including alcoholic hepatitis, Crohn's disease, ulcerative colitis and irritable bowel syndrome, experimental, investigational, or unproven.
Aetna · Identified Aug 14, 2026Medium impact
Intensive Cardiac Rehabilitation Programs (CPB 0267, reviewed 2026-05-14)
Aetna considers intensive cardiac rehabilitation programs (the Benson-Henry Institute Cardiac Wellness Program, the Ornish cardiac treatment program and the Pritikin Program) medically necessary as an alternative to traditional Phase II cardiac rehabilitation for members who meet the cardiac rehabilitation criteria, limited to 72 one-hour sessions, up to 6 per day, over a period of up to 18 weeks. Virtual delivery by real-time audio and video (excluding audio-only) is considered medically necessary when the telehealth program and member criteria are met, but hospital outpatient departments are not eligible for virtual telehealth services. Intensive cardiac rehabilitation is considered experimental, investigational or unproven for diabetes, hyperlipidemia, prostate cancer, metabolic syndrome and all other indications where effectiveness has not been established.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Free Testosterone Testing
Serum free testosterone (CPT 84402) is medically necessary to distinguish a sex hormone-binding globulin (SHBG) abnormality from hypogonadism in obese males with symptoms of hypogonadism when total testosterone is low, to diagnose hyperandrogenism in symptomatic females, and in patients with a medical diagnosis that may increase or decrease SHBG levels. It is not medically necessary to diagnose testosterone deficiency in non-obese males with symptoms of hypogonadism, or when performed for screening of asymptomatic patients. Free testosterone should be performed by equilibrium dialysis, and free testosterone measured by an analog method should never be ordered.

Watch E88.810

Get one email when a payer policy names E88.810, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code E88.810?

There are 5 tracked policy changes affecting code E88.810, including updates from Blue Cross of Idaho, Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code E88.810?

Payers that have issued tracked updates for code E88.810 include: Blue Cross of Idaho, Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code E88.810 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code E88.810. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code E88.810?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

2.01.92 - Fecal Microbiota Transplantation - name of bacteria was updated to Clostridioides (formerly Clostridium) difficile. Clarification on recurrent infection. Policy intent unchanged.

Abdominoplasty, Suction Lipectomy, and Ventral Hernia Repair (CPB 0211, reviewed 2026-08-18)

Fecal Bacteriotherapy (CPB 0844, reviewed 2026-03-25)

Intensive Cardiac Rehabilitation Programs (CPB 0267, reviewed 2026-05-14)

Free Testosterone Testing

What insurance policy changes affect code E88.810?

Which payers have updated policy for code E88.810?

How do I get notified when code E88.810 policy changes?

Why do payers change policies for code E88.810?